Sökning: "Fredrik Swartling"
Visar resultat 1 - 5 av 8 avhandlingar innehållade orden Fredrik Swartling.
1. Mechanisms of Medulloblastoma Dissemination and Novel Targeted Therapies
Sammanfattning : Medulloblastomas are the most frequent malignant childhood brain tumors, arising in the posterior fossa of children. The overall 5-year survival is 70%, although children often suffer severe long-term side effects from standard medical care. LÄS MER
2. MYC-driven Medulloblastoma : New Targeted Therapies and Mechanisms of Recurrence
Sammanfattning : Medulloblastoma is the most common malignant brain tumor of childhood. It arises in the posterior fossa but presents with distinct histological and molecular features. Hence, medulloblastoma is divided into four molecular subgroups, WNT, SHH, Group 3, and Group 4. LÄS MER
3. From Genes to Therapy : Modeling and Novel Therapeutic Strategies for Brain Tumors
Sammanfattning : Medulloblastoma is the most common malignant pediatric brain tumor and is molecularly divided into four subgroups – WNT, SHH, Group 3 and Group 4. Two thirds of medulloblastoma patients survive, but survivors often suffer from severe, lifelong side-effects. The MYCN oncogene is deregulated in many medulloblastoma patients. LÄS MER
4. Glioblastoma heterogeneity and plasticity : Investigating the roles of BMP4 and SOX2
Sammanfattning : The malignant primary brain tumor glioblastoma has a dismal prognosis and is distinguished by its heterogeneous character. Current treatment with surgical resection, radiotherapy and adjuvant chemotherapy with the alkylating agent temozolomide does not provide a cure, but simply prolongs survival by a few months. LÄS MER
5. Integrative modeling of intratumoral heterogeneity, plasticity and regulation in nervous system cancers
Sammanfattning : The adult brain tumor glioblastoma (GBM) is characterized by short survival and a lack of efficient treatments. Median survival is 15 months from time of diagnosis and the 5-year survival rate is only 7 %. LÄS MER